Introduction
============

Glutamate and γ-aminobutyric acid (GABA) are the most important excitatory and inhibitory neurotransmitters in central nervous system, respectively ([@B4]; [@B3]). Replenishment of glutamatergic and GABAergic synaptic vesicles, a fundamental step in synaptic physiology, is mediated by specific vesicular transporters termed VGLUT1-3 ([@B10]; [@B9]; [@B19]) and VGAT, respectively ([@B13]; [@B18]; [@B20]).

[@B17] reported that VGLUT1 and VGAT co-localize in developing hippocampal mossy fibers terminals. Subsequently, we demonstrated in rat adult neocortex that VGLUT1 and VGAT are co-localized in a subset of axon terminals which form both symmetric and asymmetric synapses, that they are sorted to the same vesicles, and that these vesicles participate in the exo-endocytotic cycle ([@B7]). More recently, we showed that glutamatergic and GABAergic responses can be recorded from rat cortical neurons in cultures, indicating the occurrence of glutamate and GABA co-release from neurons co-expressing VGLUT1 and VGAT (mixed synapses), and that the percentage of mixed synapses is regulated in an activity-dependent manner ([@B6]).

To date, very little is known on the occurrence of VGLUT1/VGAT co-localization in other brain regions, (see below). Based on their activity-dependent regulation, terminals co-expressing VGLUT1/VGAT appear suitable to control excitation--inhibition (E/I) balance; and on this basis we hypothesize that they may exhibit a widespread distribution in the brain. In order to test this hypothesis, we investigated the occurence of VGLUT1/VGAT terminals in different brain regions.

Co-Expression of VGLUT1 and VGAT is A Widespread Phenomenon
===========================================================

Confocal microscopy analysis revealed that in both rat and mouse brain VGLUT1/VGAT+ terminals were present in comparable amount in all brain regions studied (**Figure [1](#F1){ref-type="fig"}** and **Table [1](#T1){ref-type="table"}**).

![Confocal analysis of rat and mouse brain VGLUT1(green)/VGAT+(red) terminals. Cerebral cortex: layers II-III of S1; Striatum: caudate-putamen (CPu) nucleus; Hippocampus: Stratum Lucidum of CA3; Thalamus: anterodorsal nucleus (AD); Cerebellar cortex: granular layers. Arrowheads point to example of co-localization between VGLUT1 and VGAT. After perfusion brains were removed stereotaxically in order to obtain the regions of interest ([@B16]; [@B15]): --0.3 to --6.8 mm from the bregma for rat brain; 0.0 to --3.6 mm from the bregma for mouse brain. Sections were incubated for 1 h in newborn calf serum (NBCS; 10% in PB with 0.2% Triton X-100), and then for 2 h at room temperature plus overnight at 4°C in a solution containing a mixture of anti-VGAT (made in rabbit; Synaptic System, Germany, \#131003, [RRID:AB_887869](RRID:AB_887869); 1:500 rat, 1:400 mouse) ([@B20]) and, only in rat experiments, anti-VGLUT1 (made in guinea-pig; Millipore, Billerica, MA, United States, AB5905, [RRID:AB_2301751](RRID:AB_2301751); 1:1000) ([@B14]) primary antibodies, for mouse experiments we use fluorescent VGLUT1 (Venus) knock-in mouse ([@B12]). The next day, sections were incubated in a mixture of CY3 (Jackson ImmunoResearch, West Grove, PA, United States, \#711-166-152; 1:250) and (only in rat experiments) Alexa-488 (Jackson Immunoresearch, West Grove, PA, United States, \#706-546-148; 1:250). Images were acquired using a Leica TCS-SP2 confocal laser microscope equipped with an argon (488 nm) and a helium/neon (543 nm) using a × 63 oil immersion lens (numerical aperture 1.4; pinhole 1.0 and image size 512 × 512 pixels, yielding a pixel size of 0.155 μm (rat) and 0.133 μm (mouse) from a plane in which the resolution of both stains was optimal and never \> 1.8 μm from the surface ([@B14]). Green and red channels were acquired sequentially. To improve the signal/noise ratio, 10 frames/image were averaged. Images were deconvolved using Iterative Deconvolve 3D plugin ([@B5]) of ImageJ software (v. 1.48; NIH). Scale bars: 5 μm. Quantitative analysis of VGLUT1/VGAT co-localization in rat (up) and mouse (down) brain regions. The results show that the percentage of VGLUT1/VGAT+ terminals is comparable across regions and species. Three--four animals/regions. Data represent mean ± S.E.M.](fncel-11-00229-g001){#F1}

###### 

VGLUT1-VGAT colocalization in rat and mouse brain subregions.

                              RAT         MOUSE                   
  --------------------------- ----------- ----------- ----------- -----------
  **Cerebral Cortex**                                             
     S1                       6.7 ± 0.7   8.4 ± 0.4   2.4 ± 0.4   2.8 ± 0.4
     M1                       4.2 ± 0.5   6.1 ± 0.7   2.6 ± 0.2   4.4 ± 0.7
  **Striatum**                                                    
  *   Caudate-Putamen*        4.6 ± 0.6   4.8 ± 0.3   2.4 ± 0.2   3.1 ± 0.1
  **Hippocampus**                                                 
  **Dentate Gyrus**                                               
  *   Molecular layer*        3.7 ± 1.7   4.5 ± 1.6   2.1 ± 0.2   3.3 ± 0.1
  *   Polymorphic layer*      2.6 ± 1.0   2.7 ± 1.1   0.9 ± 0.2   1.1 ± 0.2
  **CA3**                                                         
  *   Stratum oriens*         3.2 ± 1.4   3.8 ± 1.3   2.2 ± 0.2   4.3 ± 0.3
  *   Stratum lucidum*        3.1 ± 0.8   3.7 ± 0.7   1.6 ± 0.4   2.2 ± 0.3
  *   Stratum radiatum*       2.1 ± 0.6   2.0 ± 0.1   1.5 ± 0.2   2.6 ± 0.2
  **CA1**                                                         
  *   Lacumosum-moleculare*   1.7 ± 0.9   2.9 ± 1.3   1.3 ± 0.1   3.8 ± 0.5
  *   Stratum radiatum*       1.7 ± 0.8   2.6 ± 0.9   1.3 ± 0.1   2.6 ± 0.5
  **Thalamus**                                                    
     AD                       4.5 ± 0.6   7.1 ± 1.3   2.0 ± 0.3   3.6 ± 0.6
     AV                       2.7 ± 0.7   4.9 ± 1.2   1.7 ± 0.2   3.6 ± 0.5
     PVA                      3.7 ± 0.7   4.6 ± 0.7   2.2 ± 0.2   2.8 ± 0.4
     PT                       2.3 ± 1.0   3.5 ± 1.2   1.0 ± 0.3   2.2 ± 0.3
     IAM                      3.0 ± 1.0   4.5 ± 0.9   1.3 ± 0.3   2.2 ± 0.2
     Rh                       3.8 ± 0.5   3.8 ± 0.5   1.7 ± 0.4   2.3 ± 0.2
     Re                       3.4 ± 0.5   3.8 ± 0.5   2.1 ± 0.3   2.5 ± 0.2
     CM                       2.9 ± 0.1   4.2 ± 0.4   1.1 ± 0.3   1.8 ± 0.4
     CL                       2.2 ± 0.6   3.1 ± 0.6   1.3 ± 0.3   1.9 ± 0.2
     PF                       2.6 ± 0.4   2.4 ± 0.5   1.5 ± 0.4   1.1 ± 0.4
     MD                       1.2 ± 0.6   2.5 ± 0.9   1.2 ± 0.2   2.4 ± 0.4
     VL                       2.8 ± 0.9   4.1 ± 0.9   1.5 ± 0.2   3.1 ± 0.4
     VPL                      1.2 ± 0.4   3.1 ± 1.0   1.5 ± 0.6   2.8 ± 0.5
     VPM                      1.6 ± 0.6   3.7 ± 1.0   1.0 ± 0.2   2.5 ± 0.3
     DLG                      1.5 ± 0.5   2.7 ± 1.0   1.4 ± 0.4   2.9 ± 0.7
     MGV                      1.3 ± 0.2   3.0 ± 0.5   1.3 ± 0.5   3.2 ± 0.7
  **Cerebellar Cortex**                                           
  *   Molecular layer*        1.7 ± 0.2   3.3 ± 0.6   1.4 ± 0.4   3.1 ± 0.7
  *   Granular layer*         6.5 ± 1.1   3.0 ± 0.7   4.8 ± 1.5   3.4 ± 1.4
                                                                  

Cerebral cortex: layers II-III of S1 and M1 (six fields/section; rat: one section/animal, four rats; mouse: two sections/animal, three mice); Striatum: caudate-putamen (CPu) nucleus (six fields/section, two section/animal, three animals); Hippocampus: Molecular layer and Polymorphic cell layer of the Dentate Gyrus; Stratum Oriens, Stratum Lucidum and Stratum Radiatum of CA3; Stratum Lacunosum-Moleculare and Stratum Radiatum of CA1 (three fields/layer/section, two sections/animal, three animals); Thalamus: anterior nuclear group \[anterodorsal nucleus (AD), anteroventral nucleus (AV)\]; dorsomedial nucleus (MD); midline nuclear group \[paratenial nucleus (PT), paraventricular nucleus (PVA), interanteromedial nucleus (IAM), reuniens nucleus (Re), rhomboidal nucleus (Rh)\]; intralaminar nuclei \[central lateral nucleus (CL), central medial nucleus (CM), parafascicular nucleus (PF)\]; ventral nuclear group \[ventral lateral nucleus (VL), ventral posterolateral (VPL), ventral posteromedial (VPM)\]; medial geniculate complex \[medial geniculate nucleus (MGV)\]; dorsal lateral geniculate nucleus (DLG; three fields/nucleus/section, two sections/animal, three animals); Cerebellum: Molecular and granular layers of cortex (six fields/layer/section, two sections/animal, three animals). Data represent mean ± S.E.M

.

In rat brain, the percentage of VGLUT1+ puncta co-expressing VGAT was 5.4 ± 0.5% in cerebral cortex; 4.6 ± 0.6% in striatum; 2.6 ± 1.0% in hippocampus; 2.5 ± 0.4% in thalamus; and 3.1 ± 0.6% in cerebellar cortex, while the percentage of VGAT+ puncta co-expressing VGLUT1 was 6.0 ± 0.5% in cerebral cortex; 4.8 ± 0.3% in striatum; 3.2 ± 1.0% in hippocampus; 3.8 ± 0.7% in thalamus; and 3.2 ± 0.6% in cerebellar cortex (**Figure [1](#F1){ref-type="fig"}**). Details on individual nuclei, layers or sub-regions are presented in **Table [1](#T1){ref-type="table"}**.

Mice are more widely used than rats for generating transgenic animals, an approach that could be useful in the future to define the functional role of the system of VGLUT1/VGAT co-expressing terminals; for this reason, we performed the same analysis in this species. In mouse brain, the percentage of VGLUT1+ puncta co-expressing VGAT was 2.5 ± 0.2% in cerebral cortex; 2.4 ± 0.2% in striatum; 1.6 ± 0.1% in hippocampus; 1.5 ± 0.07% in thalamus; and 2.7 ± 0.5 in cerebellar cortex, while the percentage of VGAT+ puncta co-expressing VGLUT1 was 3.6 ± 0.2% in cerebral cortex; 3.1 ± 0.07% in striatum; 2.8 ± 0.2 in hippocampus; 2.6 ± 0.1 in thalamus; and 3.1 ± 0.9 in cerebellar cortex (**Figure [1](#F1){ref-type="fig"}**). Details on individual nuclei, layers or sub-regions are given in **Table [1](#T1){ref-type="table"}**.

VGLUT1/VGAT Terminals may Contribute to E/I Balance in A Multitude of Brain Circuits
====================================================================================

In the last few years, several papers have documented that VGLUT1 and VGAT are co-expressed in cerebral cortex, hippocampus and cerebellum of rats and mice ([@B11]; [@B17]; [@B21]; [@B7]; [@B23]; [@B1]). To date, the occurrence of VGLUT1/VGAT co-expression in other brain regions of both species is poorly understood. Here, we showed for the first time that co-expression of VGLUT1 and VGAT is a widespread phenomenon, and that the co-localization of the two vesicular transporters is not markedly different between the two species, an observation that might be of some help for studying the role of VGLUT1/VGAT co-expression in animal models of neurological and psychiatric diseases.

The main data emerging from this study is that VGLUT1/VGAT+ terminals are present in all the anatomical structures studied of both species. The percentage of VGLUT1/VGAT+ terminals is regulated in an activity-dependent manner: reducing the activity of the neuronal network by addition of glutamate receptor antagonists to the cultures decreases the percentage of mixed synapses, whereas reducing spontaneous inhibition with bicuculline increases them ([@B6]). These findings support the idea that activity-dependent regulation of glutamate and GABA co-release might play a role in regulating E/I balance in cortical microcircuits, thereby contributing to regulate brain function in normal and pathological conditions. The present demonstration that VGLUT1/VGAT co-expression occurs in all brain regions studied suggests that these terminals may contribute to adjust E/I balance in a multitude of brain circuits. For example, it is well known that an abnormal increase of glutamatergic and/or an abnormal decrease of GABAergic transmission in hippocampus promotes neuronal hyperexcitability and hypersynchronization, and may sustain epileptic networks (e.g., [@B2]). The present evidence of a population of hippocampal VGLUT1/VGAT+ axon terminals, demonstrated here for the first time in adult normal animals, raises the possibility that their dysregulation may generate E/I imbalance. In addition, controlling inhibitory and excitatory sources (both local and extrinsic) in higher-order thalamic nuclei may contribute to thalamic oscillations ([@B8]), implying that VGLUT1/VGAT+ terminals-mediated E/I imbalance in these circuits may play a crucial role in some forms of epilepsy. Finally, the network of parvalbumin+ fast-spiking interneurons has attracted much interest in autism spectrum disorders (ASDs), and parvalbumin knockout mice exhibit behavioral phenotypes resembling core symptoms of the diseases. In the striatum of these mice, E/I balance is altered by modification of both inhibitory and excitatory synaptic transmission, leading to the hypothesis that down-regulation of parvalbumin might be central to the neurobiological basis of the diseases ([@B22]). In this context, it is worth noting that in fast-spiking-enriched cultures the percentage of VGLUT1/VGAT+ terminals is increased compared to controls ([@B6]), thus making it conceivable that VGLUT1/VGAT+ terminals in striatum (as well as in other brain regions) may play a role.

Conclusion
==========

We showed that VGLUT1/VGAT+ axon terminals are present in all structures studied in both rat and mouse brain. Their percentage is relatively low, but given their activity-dependent regulation, it is conceivable that they may play a role in both physiological regulation of E/I and in the pathophysiology of several neurological and psychiatric diseases.
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